ADMA BIOLOGICS, INC. Interest Expense
ADMA BIOLOGICS, INC. (ADMA) reported Interest Expense of $3.77 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-09.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-05-09
- ADMA BIOLOGICS, INC. interest expense for the quarter ending 2024-03-31 was $3.77M, a 38.36% decline year-over-year.
- ADMA BIOLOGICS, INC. interest expense for the quarter ending 2023-12-31 was $6.21M, a 8.34% increase year-over-year.
- ADMA BIOLOGICS, INC. interest expense for the quarter ending 2023-09-30 was $6.40M, a 14.64% increase year-over-year.
- ADMA BIOLOGICS, INC. interest expense for the quarter ending 2023-06-30 was $6.30M, a 37.75% increase year-over-year.
- ADMA BIOLOGICS, INC. interest expense for fiscal 2023 was $25.03M, a 29.81% increase from fiscal 2022.
- ADMA BIOLOGICS, INC. interest expense for fiscal 2022 was $19.28M, a 47.65% increase from fiscal 2021.
- ADMA BIOLOGICS, INC. interest expense for fiscal 2021 was $13.06M, a 8.94% increase from fiscal 2020.
- ADMA BIOLOGICS, INC. interest expense for fiscal 2020 was $11.99M, a 33.27% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-03-31 | $3.77M 10-Q · filed 2024-05-09 | $9.98M derived: sum of 2 quarters · filed 2024-05-09 | $16.38M derived: sum of 3 quarters · filed 2024-05-09 | $22.68M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-12-31 | $6.21M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $12.61M derived: sum of 2 quarters · filed 2024-02-28 | $18.91M derived: sum of 3 quarters · filed 2024-02-28 | $25.03M 10-K · filed 2024-02-28 | ||
| 2023-09-30 | $6.40M 10-Q · filed 2023-11-08 | $12.70M derived: sum of 2 quarters · filed 2023-11-08 | $18.81M 10-Q · filed 2023-11-08 | $24.55M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-06-30 | $6.30M 10-Q · filed 2023-08-09 | $12.41M 10-Q · filed 2023-08-09 | $18.15M derived: sum of 3 quarters · filed 2024-05-09 | $23.73M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2023-03-31 | $6.12M 10-Q · filed 2024-05-09 | $6.12M 10-Q · filed 2023-05-10 | $11.85M derived: sum of 2 quarters · filed 2024-05-09 | $17.43M derived: sum of 3 quarters · filed 2024-05-09 | $22.00M derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $11.32M derived: sum of 2 quarters · filed 2024-02-28 | $15.89M derived: sum of 3 quarters · filed 2024-02-28 | $19.28M 10-K · filed 2024-02-28 | $19.28M 10-K · filed 2023-03-23 | |
| 2022-09-30 | $5.58M 10-Q · filed 2023-11-08 | $10.15M derived: sum of 2 quarters · filed 2023-11-08 | $13.54M 10-Q · filed 2023-11-08 | $16.86M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-06-30 | $4.57M 10-Q · filed 2023-08-09 | $7.96M 10-Q · filed 2023-08-09 | $11.28M derived: sum of 3 quarters · filed 2024-02-28 | $14.58M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2022-03-31 | $3.39M 10-Q · filed 2023-05-10 | $6.70M derived: sum of 2 quarters · filed 2024-02-28 | $10.00M derived: sum of 3 quarters · filed 2024-02-28 | $13.25M derived: sum of 4 quarters · filed 2024-02-28 | ||
| 2021-12-31 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $6.61M derived: sum of 2 quarters · filed 2024-02-28 | $9.86M derived: sum of 3 quarters · filed 2024-02-28 | $13.06M 10-K · filed 2024-02-28 | $13.06M 10-K · filed 2022-03-24 | |
| 2021-09-30 | $3.30M 10-Q · filed 2022-11-09 | $6.55M derived: sum of 2 quarters · filed 2022-11-09 | $9.74M 10-Q · filed 2022-11-09 | $12.85M derived: sum of 4 quarters · filed 2022-11-09 | ||
| 2021-06-30 | $3.25M 10-Q · filed 2022-08-10 | $6.44M 10-Q · filed 2022-08-10 | $9.55M derived: sum of 3 quarters · filed 2022-08-10 | $12.64M derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $3.20M 10-Q · filed 2022-05-11 | $6.31M derived: sum of 2 quarters · filed 2022-05-11 | $9.40M derived: sum of 3 quarters · filed 2022-05-11 | $12.46M derived: sum of 4 quarters · filed 2022-05-11 | ||
| 2020-12-31 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $6.20M derived: sum of 2 quarters · filed 2022-03-24 | $9.27M derived: sum of 3 quarters · filed 2022-03-24 | $11.99M 10-K · filed 2022-03-24 | ||
| 2020-09-30 | $3.09M 10-Q · filed 2021-11-10 | $6.16M derived: sum of 2 quarters · filed 2021-11-10 | $8.88M 10-Q · filed 2021-11-10 | $11.61M derived: sum of 4 quarters · filed 2021-11-10 | ||
| 2020-06-30 | $3.07M 10-Q · filed 2021-08-11 | $5.78M 10-Q · filed 2021-08-11 | $8.52M derived: sum of 3 quarters · filed 2021-08-11 | $11.16M derived: sum of 4 quarters · filed 2021-08-11 | ||
| 2020-03-31 | $2.72M 10-Q · filed 2021-05-12 | $5.45M derived: sum of 2 quarters · filed 2021-05-12 | $8.10M derived: sum of 3 quarters · filed 2021-05-12 | $10.17M derived: sum of 4 quarters · filed 2021-05-12 | ||
| 2019-12-31 | $2.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $5.38M derived: sum of 2 quarters · filed 2021-03-25 | $7.45M derived: sum of 3 quarters · filed 2021-03-25 | $8.99M 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $2.65M 10-Q · filed 2020-11-05 | $4.72M derived: sum of 2 quarters · filed 2020-11-05 | $6.26M 10-Q · filed 2020-11-05 | $7.70M derived: sum of 4 quarters · filed 2020-11-05 | ||
| 2019-06-30 | $2.07M 10-Q · filed 2020-08-05 | $3.61M 10-Q · filed 2020-08-05 | $5.05M derived: sum of 3 quarters · filed 2020-08-05 | $6.45M derived: sum of 4 quarters · filed 2020-08-05 | ||
| 2019-03-31 | $1.54M 10-Q · filed 2020-05-06 | $2.98M derived: sum of 2 quarters · filed 2020-05-06 | $4.38M derived: sum of 3 quarters · filed 2020-05-06 | $5.74M derived: sum of 4 quarters · filed 2020-05-06 | ||
| 2018-12-31 | $1.44M 10-K · filed 2019-03-13 | $2.84M derived: sum of 2 quarters · filed 2019-11-06 | $4.20M derived: sum of 3 quarters · filed 2019-11-06 | $5.52M 10-K · filed 2020-03-13 | ||
| 2018-09-30 | $1.40M 10-Q · filed 2019-11-06 | $2.76M derived: sum of 2 quarters · filed 2019-11-06 | $4.08M 10-Q · filed 2019-11-06 | $5.33M derived: sum of 4 quarters · filed 2019-11-06 | ||
| 2018-06-30 | $1.36M 10-Q · filed 2019-08-08 | $2.68M 10-Q · filed 2019-08-08 | $3.92M derived: sum of 3 quarters · filed 2019-08-08 | $4.71M derived: sum of 4 quarters · filed 2019-08-08 | ||
| 2018-03-31 | $1.32M 10-Q · filed 2019-05-08 | $2.57M derived: sum of 2 quarters · filed 2019-05-08 | $3.35M derived: sum of 3 quarters · filed 2019-05-08 | $3.99M derived: sum of 4 quarters · filed 2019-05-08 | ||
| 2017-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | $2.02M derived: sum of 2 quarters · filed 2019-03-13 | $2.67M derived: sum of 3 quarters · filed 2019-03-13 | $3.29M 10-K · filed 2019-03-13 | ||
| 2017-09-30 | $782.97K 10-Q · filed 2018-11-09 | $1.43M derived: sum of 2 quarters · filed 2018-11-09 | $2.04M 10-Q · filed 2018-11-09 | $2.67M derived: sum of 4 quarters · filed 2018-11-09 | ||
| 2017-06-30 | $642.49K 10-Q · filed 2018-08-10 | $1.26M 10-Q · filed 2018-08-10 | $1.89M derived: sum of 3 quarters · filed 2018-08-10 | $2.50M derived: sum of 4 quarters · filed 2018-08-10 | ||
| 2017-03-31 | $618.53K 10-Q · filed 2018-05-14 | $1.25M derived: sum of 2 quarters · filed 2018-05-14 | $1.85M derived: sum of 3 quarters · filed 2018-05-14 | $2.39M derived: sum of 4 quarters · filed 2018-05-14 | ||
| 2016-12-31 | $628.16K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $1.23M derived: sum of 2 quarters · filed 2018-03-29 | $1.77M derived: sum of 3 quarters · filed 2018-03-29 | $2.24M 10-K · filed 2018-03-29 | ||
| 2016-09-30 | $605.97K 10-Q · filed 2017-11-03 | $1.14M derived: sum of 2 quarters · filed 2017-11-03 | $1.61M 10-Q · filed 2017-11-03 | $2.08M derived: sum of 4 quarters · filed 2017-11-03 | ||
| 2016-06-30 | $538.00K 10-Q · filed 2017-08-11 | $1.01M 10-Q · filed 2017-08-11 | $1.47M derived: sum of 3 quarters · filed 2017-08-11 | $1.92M derived: sum of 4 quarters · filed 2017-08-11 | ||
| 2016-03-31 | $467.44K 10-Q · filed 2017-05-12 | $931.38K derived: sum of 2 quarters · filed 2017-05-12 | $1.38M derived: sum of 3 quarters · filed 2017-05-12 | $1.83M derived: sum of 4 quarters · filed 2017-05-12 | ||
| 2015-12-31 | $463.94K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $913.27K derived: sum of 2 quarters · filed 2017-02-24 | $1.37M derived: sum of 3 quarters · filed 2017-02-24 | $1.84M 10-K · filed 2017-02-24 | ||
| 2015-09-30 | $449.33K 10-Q · filed 2016-11-10 | $902.74K derived: sum of 2 quarters · filed 2016-11-10 | $1.38M 10-Q · filed 2016-11-10 | $1.76M derived: sum of 4 quarters · filed 2016-11-10 | ||
| 2015-06-30 | $453.41K 10-Q · filed 2016-08-12 | $929.45K 10-Q · filed 2016-08-12 | $1.31M derived: sum of 3 quarters · filed 2016-08-12 | $1.65M derived: sum of 4 quarters · filed 2016-08-12 | ||
| 2015-03-31 | $476.04K 10-Q · filed 2016-05-13 | $857.32K derived: sum of 2 quarters · filed 2016-05-13 | $1.19M derived: sum of 3 quarters · filed 2016-05-13 | $1.54M derived: sum of 4 quarters · filed 2016-05-13 | ||
| 2014-12-31 | $381.28K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-23 | $716.58K derived: sum of 2 quarters · filed 2016-03-23 | $1.06M derived: sum of 3 quarters · filed 2016-03-23 | $1.29M 10-K · filed 2016-03-23 | ||
| 2014-09-30 | $335.30K 10-Q · filed 2015-11-10 | $678.05K derived: sum of 2 quarters · filed 2015-11-10 | $904.93K 10-Q · filed 2015-11-10 | $1.07M derived: sum of 4 quarters · filed 2015-11-10 | ||
| 2014-06-30 | $342.75K 10-Q · filed 2015-08-11 | $569.63K 10-Q · filed 2015-08-11 | $737.29K derived: sum of 3 quarters · filed 2015-08-11 | $900.22K derived: sum of 4 quarters · filed 2015-08-11 | ||
| 2014-03-31 | $226.88K 10-Q · filed 2015-05-12 | $394.54K derived: sum of 2 quarters · filed 2015-05-12 | $557.47K derived: sum of 3 quarters · filed 2015-05-12 | $716.31K derived: sum of 4 quarters · filed 2015-05-12 | ||
| 2013-12-31 | $167.65K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $330.58K derived: sum of 2 quarters · filed 2015-03-09 | $489.43K derived: sum of 3 quarters · filed 2015-03-09 | $618.23K 10-K · filed 2015-03-09 | ||
| 2013-09-30 | $162.93K 10-Q · filed 2014-11-10 | $321.78K derived: sum of 2 quarters · filed 2014-11-10 | $450.57K 10-Q · filed 2014-11-10 | $467.02K derived: sum of 4 quarters · filed 2014-11-10 | ||
| 2013-06-30 | $158.84K 10-Q · filed 2014-08-11 | $287.64K 10-Q · filed 2014-08-11 | $304.08K derived: sum of 3 quarters · filed 2014-08-11 | $306.73K derived: sum of 4 quarters · filed 2014-08-11 | ||
| 2013-03-31 | $128.80K 10-Q · filed 2014-05-12 | $145.24K derived: sum of 2 quarters · filed 2014-05-12 | $147.89K derived: sum of 3 quarters · filed 2014-05-12 | $150.99K derived: sum of 4 quarters · filed 2014-05-12 | ||
| 2012-12-31 | $16.44K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $19.09K derived: sum of 2 quarters · filed 2014-03-28 | $22.19K derived: sum of 3 quarters · filed 2014-03-28 | $30.68K 10-K · filed 2014-03-28 | ||
| 2012-09-30 | $2.65K 10-Q · filed 2013-11-12 | $5.75K derived: sum of 2 quarters · filed 2013-11-12 | $14.24K 10-Q · filed 2013-11-12 | |||
| 2012-06-30 | $3.10K 10-Q · filed 2013-08-12 | $11.59K 10-Q · filed 2013-08-12 | ||||
| 2012-03-31 | $8.49K 10-Q · filed 2013-05-14 | |||||
| 2011-12-31 | $1.60M 10-K · filed 2013-03-06 | |||||
| 2011-06-30 | $240.03K 10-Q · filed 2012-08-14 | $556.16K 10-Q · filed 2012-08-14 | ||||
| 2011-03-31 | $316.14K 10-Q · filed 2012-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |